Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Neuro-Oncology Advances
|
May 17, 2023
The brain-penetrant cell-cycle inhibitor p28 sensitizes brain metastases to DNA-damaging agents
Sunam Mander, Gregory S Gorman, Lori U Coward, et al.
Oncogene
|
April 6, 2004
Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice
Elena A Komarova, Roman V Kondratov, Kaihua Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2004
Multiple myeloma regression mediated by bruceantin
Muriel Cuendet, Konstantin Christov, Daniel D Lantvit, et al.
Cancer Research
|
July 20, 2007
Hemizygous disruption of Cdc25A inhibits cellular transformation and mammary tumorigenesis in mice
Dipankar Ray, Yasuhisa Terao, Dipali Nimbalkar, et al.
Breast Cancer Research and Treatment
|
February 27, 2003
Cell proliferation, apoptosis, and expression of cyclin D1 and cyclin E as potential biomarkers in tamoxifen-treated mammary tumors
Konstantin Christov, Amy Ikui, Anne Shilkaitis, et al.
Molecular Cancer Therapeutics
|
May 2, 2006
Effects of the farnesyl transferase inhibitor R115777 (Zarnestra) on mammary carcinogenesis: prevention, therapy, and role of HaRas mutations
Ronald A Lubet, Konstantin Christov, Ming You, et al.
Ebiomedicine
|
February 2, 2022
Image-guided surgery with a new tumour-targeting probe improves the identification of positive margins
Masahide Goto, Ingeun Ryoo, Samer Naffouje, et al.
Carcinogenesis
|
December 14, 2004
Efficacy of Targretin on methylnitrosourea-induced mammary cancers: prevention and therapy dose-response curves and effects on proliferation and apoptosis
Ronald A Lubet, Konstantin Christov, Nomeli P Nunez, et al.
Molecular Cancer Therapeutics
|
April 1, 2008
Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes
Ronald A Lubet, Eva Szabo, Konstantin Christov, et al.
Endocrinology
|
June 23, 2007
Advanced rat mammary cancers are growth hormone dependent
Qi Shen, Daniel D Lantvit, Qing Lin, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Neuro-Oncology Advances
|
May 17, 2023
The brain-penetrant cell-cycle inhibitor p28 sensitizes brain metastases to DNA-damaging agents
Sunam Mander, Gregory S Gorman, Lori U Coward, et al.
Oncogene
|
April 6, 2004
Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice
Elena A Komarova, Roman V Kondratov, Kaihua Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2004
Multiple myeloma regression mediated by bruceantin
Muriel Cuendet, Konstantin Christov, Daniel D Lantvit, et al.
Cancer Research
|
July 20, 2007
Hemizygous disruption of Cdc25A inhibits cellular transformation and mammary tumorigenesis in mice
Dipankar Ray, Yasuhisa Terao, Dipali Nimbalkar, et al.
Breast Cancer Research and Treatment
|
February 27, 2003
Cell proliferation, apoptosis, and expression of cyclin D1 and cyclin E as potential biomarkers in tamoxifen-treated mammary tumors
Konstantin Christov, Amy Ikui, Anne Shilkaitis, et al.
Molecular Cancer Therapeutics
|
May 2, 2006
Effects of the farnesyl transferase inhibitor R115777 (Zarnestra) on mammary carcinogenesis: prevention, therapy, and role of HaRas mutations
Ronald A Lubet, Konstantin Christov, Ming You, et al.
Ebiomedicine
|
February 2, 2022
Image-guided surgery with a new tumour-targeting probe improves the identification of positive margins
Masahide Goto, Ingeun Ryoo, Samer Naffouje, et al.
Carcinogenesis
|
December 14, 2004
Efficacy of Targretin on methylnitrosourea-induced mammary cancers: prevention and therapy dose-response curves and effects on proliferation and apoptosis
Ronald A Lubet, Konstantin Christov, Nomeli P Nunez, et al.
Molecular Cancer Therapeutics
|
April 1, 2008
Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes
Ronald A Lubet, Eva Szabo, Konstantin Christov, et al.
Endocrinology
|
June 23, 2007
Advanced rat mammary cancers are growth hormone dependent
Qi Shen, Daniel D Lantvit, Qing Lin, et al.
Page
of 5